Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer

Clinical Lung Cancer

Volumn 15, Issue 3, 2014, Pages 213-221

  Kim, Jin Soo ^a,b   Kim, Edward S ^a   Liu, Diane ^a   Lee, J Jack ^a   Solis, Luisa ^a   Behrens, Carmen ^a   Lippman, Scott M ^a   Hong, Waun Ki ^a   Wistuba, Ignacio I ^a   Lee, Ho Young ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Seoul National University   (South Korea)

Author keywords

Carcinoma; IGF Type 1; IGF Type 2; Non Small Cell Lung; Prognosis; Survival

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; WILD TYPE; ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, IGF TYPE 1; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897989637     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.12.006     Document Type: Article

References (31)

1. A. Jemal, F. Bray, and M.M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. F. Janku, D.J. Stewart, and R. Kurzrock Targeted therapy in non-small-cell lung cancer - is it becoming a reality? Nat Rev Clin Oncol 7 2010 401 414
3. M. Pollak The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat Rev Cancer 12 2012 159 169
4. D.B. Ulanet, D.L. Ludwig, and C.R. Kahn et al. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy Proc Natl Acad Sci U S A 107 2010 10791 10798
5. J.S. Kim, E.S. Kim, and D. Liu et al. Prognostic impact of insulin receptor expression on survival of patients with non-small cell lung cancer Cancer 118 2012 2454 2465
6. J.B. Douglas, D.T. Silverman, and M.N. Pollak et al. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Cancer Epidemiol Biomarkers Prev 19 2010 2298 2306
7. M.R. Spitz, M.J. Barnett, and G.E. Goodman et al. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort Cancer Epidemiol Biomarkers Prev 11 2002 1413 1418 (Pubitemid 35340378)
8. J. Ahn, S.J. Weinstein, and K. Snyder et al. No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk Cancer Epidemiol Biomarkers Prev 15 2006 2010 2012 (Pubitemid 44664284)
9. T. Izycki, E. Chyczewska, and W. Naumnik et al. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy Exp Oncol 26 2004 316 319
10. J.Y. Han, B.G. Choi, and J.Y. Choi et al. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer Lung Cancer 54 2006 227 234 (Pubitemid 44764920)
11. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
12. P. Yuan, H. Kadara, and C. Behrens et al. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung PloS One 5 2010 e9112
13. W.D. Travis, E. Brambilla, and H.K. Muller-Hermelink et al. Tumours of the lung W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart 2004 International Agency for Research on Cancer Lyon, France 9 124
14. W.Y. Kim, L. Prudkin, and L. Feng et al. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors Cancer 118 2012 3993 4003
15. T. Yamamoto, T. Oshima, and K. Yoshihara et al. Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer Exp Ther Med 3 2012 797 802
16. Y.H. Kim, S. Sumiyoshi, and S. Hashimoto et al. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer Clin Lung Cancer 13 2012 385 390
17. R. Dziadziuszko, D.T. Merrick, and S.E. Witta et al. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression J Clin Oncol 28 2010 2174 2180
18. Y.S. Chang, G. Kong, and S. Sun et al. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer Clin Cancer Res 8 2002 3796 3802 (Pubitemid 35424772)
19. V.A. Papadimitrakopoulou, E.N. Brown, and D.D. Liu et al. The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis Cancer Lett 239 2006 136 143 (Pubitemid 43946585)
20. S.J. London, J.M. Yuan, and G.S. Travlos et al. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China J Natl Cancer Inst 94 2002 749 754 (Pubitemid 34567959)
21. A. Lukanova, P. Toniolo, and A. Akhmedkhanov et al. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women Int J Cancer 92 2001 888 892 (Pubitemid 32467380)
22. D.D. Karp, L.G. Paz-Ares, and S. Novello et al. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer J Clin Oncol 27 2009 2516 2522
23. A. Gualberto, M.L. Hixon, and D.D. Karp et al. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab Br J Cancer 104 2011 68 74
24. K. Masago, S. Fujita, and Y. Togashi et al. Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancer Oncol Rep 26 2011 795 803
25. M.A. Vollebergh, I. Kappers, and H.M. Klomp et al. Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer J Thorac Oncol 5 2010 1939 1948
26. A. Weickhardt, R. Doebele, and A. Oton et al. A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancer J Thorac Oncol 7 2012 419 426
27. P.J. Vlachostergios, I. Gioulbasanis, and K. Kamposioras et al. Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients Oncology 81 2011 113 118
28. M.J. Fidler, S. Basu, and L. Buckingham et al. Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer Anticancer Res 32 2012 1705 1710
29. R.K. Junnila, E.O. List, and D.E. Berryman et al. The GH/IGF-1 axis in ageing and longevity Nat Rev Endocrinol 9 2013 366 376
30. J. Saegusa, S. Yamaji, and K. Ieguchi et al. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling J Biol Chem 284 2009 24106 24114
31. D. Yee Insulin-like growth factor receptor inhibitors: baby or the bathwater? J Natl Cancer Inst 104 2012 975 981